Clinical Trials
20 trialsNCT05581121 2026-05-26
PAROLA
Institut Claudius Regaud
Phase 3 Recruiting
NCT07216703 2026-05-22
TroFuse-036
Merck Sharp & Dohme LLC
Phase 3 Recruiting
NCT07418749 2026-04-06
A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3 Recruiting
NCT05078047 2025-06-05
MOIO
UNICANCER
Phase 3 Recruiting
NCT06459687 2025-05-14
Phase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent, or Metastatic Cervical Cancer
Lee's Pharmaceutical Limited
Phase 3 Recruiting
NCT06641635 2025-03-18
Moderated Hypofractionated Online Adaptive Radiotherapy in Cervical Cancer
Peking Union Medical College Hospital
Phase 3 Recruiting
NCT06692166 2024-11-22
A Study to Evaluate 9MW2821 Versus Treatment of Physician's Choice for Subjects With Recurrent or Metastatic Cervical Cancer
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 3 Recruiting
NCT05764044 2024-07-30
AddChemo
Hospital do Coracao
Phase 3 Recruiting
NCT06509724 2024-07-26
POHIM-P3
Samsung Medical Center
Phase 3 Recruiting
NCT04422366 2024-06-07
Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
Shanghai Bovax Biotechnology Co., Ltd.
Phase 3 Recruiting
NCT04895020 2024-04-17
Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years
Shanghai Bovax Biotechnology Co., Ltd.
Phase 3 Recruiting
NCT05027776 2024-04-17
Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years
Shanghai Bovax Biotechnology Co., Ltd.
Phase 3 Recruiting
NCT05173272 2023-12-27
Induction Chemotherapy Combined With Immunotherapy Followed by Concurrent Chemoradiation in Advanced Cervical Cancer
Sichuan Cancer Hospital and Research Institute
Phase 3 Recruiting
NCT03534713 2023-09-21
ONCOCOL01
University Hospital, Toulouse
Phase 3 Recruiting
NCT04989647 2023-09-07
CERVANTES
The Central and Eastern European Gynecologic Oncology Group
Phase 3 Recruiting
NCT05735145 2023-02-21
Concurrent Chemoradiotherapy Combined With Adjuvant Chemotherapy Treated Advanced Cervical Cancer
Fourth Affiliated Hospital of Guangxi Medical University
Phase 3 Recruiting
NCT05277688 2022-09-16
Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer Patients
Ruijin Hospital
Phase 3 Recruiting
NCT05367206 2022-05-10
N6C
Sun Yat-sen University
Phase 3 Recruiting
NCT04974346 2022-01-25
PAILACC
Zhejiang Cancer Hospital
Phase 3 Recruiting
NCT04733820 2021-02-02
Clinical Efficacy of Adjuvant Chemotherapy in Patients With Locally Advanced Cervical Cancer Who Did Not Meet the NCCN Guidelines for Adjuvant Treatment After NACT Combined With Surgery
Huazhong University of Science and Technology
Phase 3 Recruiting